The healthcare sector is experiencing a significant transformation, fueled by technological advancements, evolving patient expectations, and an increasing emphasis on value-based care. The integration of digital health technologies, such as telemedicine, wearable devices, and remote patient monitoring, is revolutionizing how healthcare services are delivered. The rise of artificial intelligence (AI) in diagnostics, predictive analytics, and personalized medicine is enhancing treatment outcomes while reducing operational costs. Additionally, the expansion of biotechnology and genomics is paving the way for breakthroughs in precision medicine, gene therapy, and vaccine development. In response to the global health challenges, there is a significant push toward sustainable healthcare solutions, with a focus on reducing waste and optimizing resource utilization. The adoption of robotic surgeries, 3D-printed implants, and nanotechnology is reshaping patient care, offering minimally invasive and highly effective treatment options. Meanwhile, the growing demand for mental health solutions has emphasized developing innovative therapies and digital tools to address psychological well-being.
Navistrat Analytics provides comprehensive market research reports that delve into these transformative trends, offering actionable insights into the evolving landscape of the healthcare sector. From advancements in digital health to breakthroughs in biotechnology and robotic healthcare, our reports equip businesses with the knowledge to innovate and thrive.
Unlock the future of healthcare with our reports.
The global single-use bioreactors market size reached USD 4.17 billion in 2024 and is expected to register a revenue CAGR of 14.7% during the forecast period. Increasing adoption of bioreactors for media preparation, cell cultivation, process development, optimization, and microbial processes is driving market revenue growth. [...]
The nucleic acid therapeutics CDMO market size reached USD 4,558.8 million in 2024 and is expected to register a revenue CAGR of 13.5% during the forecast period. The ability of Nucleic Acid Therapeutics (NAT) to target both coding and non-coding sequences has gained more attention in recent years, and regulatory bodies have approved several nucleic acid modalities for therapeutic use, including siRNA, mRNA, aptamer, and antisense oligo. [...]
The oligonucleotide CDMO market size reached USD 2,883.2 million in 2024 and is expected to register a revenue CAGR of 22.9% during the forecast period. Oligonucleotide (oligo) therapies are synthesized DNA or RNA strands that bind to a specific gene or protein sequence. Oligonucleotides, which comprise DNA-based ASOs, small interfering RNAs (siRNAs), and other oligonucleotide variations, have excellent specificity and show promise for treating malignancies, genetic illnesses, and other conditions. [...]
The bispecific antibody therapeutics contract manufacturing market size reached USD 5,547.3 million in 2024 and is expected to register a revenue CAGR of 37.6% during the forecast period. Bispecific antibodies (bsAbs) are genetically engineered recombinant proteins with two distinct domains that bind to two antigens or epitopes at the same time. Bispecific antibody development is also driving advances in bioprocessing techniques, from expression to upstream processing and candidate purification. [...]
The Antisense Oligonucleotide (ASO) therapeutics market size reached USD 2,355.4 million in 2024 and is expected to register a revenue CAGR of 16.2% during the forecast period. Antisense oligonucleotides (ASOs) are short, synthetic, single-stranded oligodeoxynucleotides that can change RNA and reduce, restore, or regulate protein expression through various processes. [...]
The monoclonal antibodies market size reached USD 232.58 billion in 2024 and is expected to register a revenue CAGR of 11.5% during the forecast period. Monoclonal antibodies (mAbs) are immunoglobulins generated from a monoclonal cell line with a predetermined specificity. Their immunological activity is based on binding to a specific ligand or antigen, but they may also rely on additional effector functions. [...]
The natural killer cell therapeutics market size reached USD 658.7 million in 2024 and is expected to register a revenue CAGR of 42.7% during the forecast period. Natural killer cell therapy is a sort of cellular immunotherapy, like CAR T-cell therapy. Natural killer cells (NK) are a promising alternative platform for cellular immunotherapy and an important type of innate immune regulatory cell. NK cells can rapidly kill many nearby cancer cells due to their non-MHC-restrictive effects. [...]
The microbiome therapeutics market size reached USD 176.4 million in 2024 and is expected to register a revenue CAGR of 32.8% during the forecast period. Microbiome therapeutics aim to manipulate the gut microbiome by additive, subtractive, or modulatory therapy that includes native or created bacteria, antibiotics, bacteriophages, and bacteriocins. [...]
The functional genomics market size reached USD 10.55 billion in 2024 and is expected to register a revenue CAGR of 13.6% during the forecast period. Functional genomics is a technique to studying the function of genes and gene products, how they are regulated, and the effects of genome-wide variation on an organism's biology. Functional genomics techniques could be valuable in the clinic, especially for uncommon diseases and cancer, to support the interpretation of genomic information. [...]
The continuous bioprocessing market size reached USD 367.2 million in 2024 and is expected to register a revenue CAGR of 21.4% during the forecast period. Continuous bioprocessing is a single-unit operation in biomanufacturing in which raw materials are constantly loaded, processed, and unloaded. [...]
The baculovirus expression system market size reached USD 355.7 million in 2024 and is expected to register a revenue CAGR of 8.9% during the forecast period. The baculovirus expression vector system (BEVS) platform has established itself as a reliable manufacturing platform for viral vaccines and gene therapy vectors. [...]
The CAR T-cell therapy market size reached USD 4,557.5 million in 2024 and is expected to register a revenue CAGR of 26.9% during the forecast period. CAR T-cell therapy is a type of cancer immunotherapy treatment that employs genetically modified immune cells known as T cells to better locate and destroy cancer cells. [...]
The 4D Printing in healthcare market size reached USD 15.4 million in 2024 and is expected to register a revenue CAGR of 28.8% during the forecast period. 4D printing emerges as a shape-shifting manufacturing paradigm for the health care business, with exceptional potential for creating smart and personalized medical devices that reach patients worldwide, including in remote and low- and middle-income settings. [...]
The whole genome bisulfite sequencing market size reached USD 288.8 million in 2024 and is expected to register a revenue CAGR of 17.7% during the forecast period. Whole-genome bisulfite sequencing (WGBS) is a high-resolution sequencing technology used to determine the methylation state of cytosine bases in DNA molecules. It is becoming a more accessible method, with applications ranging from fundamental to disease research. [...]
The life sciences translation services market size reached USD 1,338.6 million in 2024 and is expected to register a revenue CAGR of 9.1% during the forecast period. Translation is essential for medical products to serve the worldwide population, especially people from varied backgrounds. Beyond translation, partnering with a language service provider (LSP) can benefit life sciences businesses. They have the potential to become a significant and trustworthy partner throughout the globalization process. [...]